ABSTRACT
Death-associated protein kinase (DAPK) is a serine-threonine kinase with tumor suppressor function. Previously, we demonstrated that tumor necrosis factor (TNF) induced DAPK-mediated apoptosis in colorectal cancer. However, the protein–protein interaction network associated with TNF–DAPK signaling still remains unclear. We identified HSF1 as a new DAPK phosphorylation target in response to low concentrations of TNF and verified a physical interaction between DAPK and HSF1 both in vitro and in vivo. We show that HSF1 binds to the DAPK promoter. Transient overexpression of HSF1 protein led to an increase in DAPK mRNA level and consequently to an increase in the amount of apoptosis. By contrast, treatment with a DAPK-specific inhibitor as well as DAPK knockdown abolished the phosphorylation of HSF1 at Ser230 (pHSF1Ser230). Furthermore, translational studies demonstrated a positive correlation between DAPK and pHSF1Ser230 protein expression in human colorectal carcinoma tissues. Taken together, our data define a novel link between DAPK and HSF1 and highlight a positive-feedback loop in DAPK regulation under mild inflammatory stress conditions in colorectal tumors. For the first time, we show that under TNF the pro-survival HSF1 protein can be redirected to a pro-apoptotic program.
Footnotes
Competing interests
The authors declare no competing interests.
Author contributions
N.B. carried out most of the experiments. J.I. performed cellular fractionation and immunoblotting experiments. T.T.R., A.A. and S.S. analyzed the tissue microarrays. J.S.-L. generated HSF1 mutants. S.C. and M.G. performed immunoblotting experiments. E.Z. and T.F. performed and analyzed phosphopeptide arrays. S.M. performed bioinformatical modeling. V.M. and H.S. generated in silico models, analyzed bioinformatical data and wrote the manuscript chapter. L.D. designed irradiation tissue microarrays. R.S.-S. and N.B. designed experiments, analyzed data and wrote the manuscript. All authors read and approved the final manuscript.
Funding
This work was supported by research grants from the Deutsche Forschungsgemeinschaft [grant number SCHN477-9-2 to R.S.-S.]; Manfred-Stolte Stiftung [grant numbers 38736003, 38736005, 38736007 to R.S.-S.]; Interdisciplinary Centre for Clinical Research [grant number IZKF-D18 to R.S.-S.]; and Deutsche Krebshilfe [grant number 107153 (TP3) to T.F.].
Supplementary material available online at http://jcs.biologists.org/lookup/suppl/doi:10.1242/jcs.157024/-/DC1
- Received May 22, 2014.
- Accepted October 20, 2014.
- © 2014. Published by The Company of Biologists Ltd